All Stories

  1. Assessment of genetically modified soybean GMB151 × DAS‐44406‐6 (application GMFF‐2024‐21774, EFSA‐Q‐2024‐00330)
  2. Assessment of genetically modified soybean MON 87705 for renewal authorisation under Regulation (EC) No 1829/2003 (application GMFF‐2023‐21236)
  3. Assessment of genetically modified soybean MON 87769 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF‐2023‐21253)
  4. Assessment of genetically modified soybean MON 94313 (application GMFF‐2022‐6595)
  5. What makes a food protein unsafe?
  6. Enzymatic production of pectic oligosaccharides
  7. Assessment of genetically modified cotton GHB614 × T304‐40 × GHB119 × COT102 (application EFSA‐GMO‐ES‐2017‐147)
  8. Assessment of genetically modified cotton T304‐40 × GHB119 × COT102 (application EFSA‐GMO‐BE‐2018‐155)
  9. Assessment of genetically modified maize DP202216 × NK603 × DAS‐40278‐9 (application GMFF‐2022‐6232)
  10. Assessment of genetically modified maize MON 87460 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF‐2023‐21251)
  11. Assessment of genetically modified maize NK603 × T25 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF‐2023‐21252)
  12. Assessment of genetically modified oilseed rape LBFLFK (application EFSA‐GMO‐DE‐2019‐157)
  13. Refining the safety assessment of newly expressed proteins in GMOs
  14. Optimization and enzymatic intensification of bioactive compound extraction from carob pulps with potential weight management applications
  15. Assessment of genetically modified soybean MON 94637 (application GMFF‐2023‐21116)
  16. Microbial dynamics, alkaloid stability, and lactose degradation of poppy seed kefir during fermentation and cold storage
  17. In Vitro Investigation of the Effects of the Food Additives Monosodium Glutamate and Allura Red AC on the human Gut Microbiota and Intestinal Cell Lines
  18. Assessment of genetically modified T25 maize for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF‐2024‐22651)
  19. Assessment of genetically modified cotton GHB614 × LLCotton25 for renewal authorisation under regulation (EC) No 1829/2003 (dossier GMFF‐2024‐21890)
  20. Current practice, challenges and future opportunities in the safety assessment of newly expressed proteins in genetically modified plants
  21. New developments in biotechnology applied to animals: An assessment of the adequacy and sufficiency of current EFSA guidance for animal risk assessment
  22. Exploring the Impact of Olive-Derived Bioactive Components on Gut Microbiota: Implications for Digestive Health
  23. Assessment of genetically modified soybean DBN9004 (application EFSA‐GMO‐BE‐2019‐165)
  24. Assessment of genetically modified cotton T304‐40 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF‐2024‐23010)
  25. Assessment of genetically modified maize NK603 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF‐2023‐21250)
  26. Assessment of genetically modified cotton MON 88913 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF‐2023‐21234)
  27. Assessment of genetically modified maize MON 87427 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF‐2023‐21254)
  28. Assessment of genetically modified oilseed rape MON 88302 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF‐2023‐21220)
  29. Assessment of genetically modified soybean MON 87708 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF‐2023‐21237)
  30. Assessment of genetically modified sugar beet KWS20‐1 (application GMFF‐2023‐14732)
  31. Mo1409: METABOLISM OF PEANUT BY ORO-GASTROINTESTINAL BACTERIA ALTERS ALLERGIC RESPONSES
  32. Global Status, Recent Trends, and Knowledge Mapping of Olive Bioactivity Research Through Bibliometric Analysis (2000–2024)
  33. Assessment of genetically modified maize DAS1131 (application GMFF‐2021‐1530)
  34. Modification of green banana and maize starches: A comparative study to select an ingredient with functional and technological potential
  35. Microbial metabolism of food allergens determines the severity of IgE-mediated anaphylaxis
  36. Biochemical properties and functions of pectin and hemicellulose polysaccharides and derived oligosaccharides: impact on human health
  37. Enzymatic synthesis of β-galactosylated xylitol derivatives modulates gut microbiota and improves obesity-related metabolic parameters in mice
  38. Cysteine proteases from plants: Utilization in foods and nutraceuticals and characterization approaches for quality management
  39. Assessment of genetically modified maize DP51291 (application GMFF‐2021‐0071)
  40. Assessment of soy leghemoglobin produced from genetically modified Komagataella phaffii, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2019‐162)
  41. Investigating technological processing supporting the assessment of novel proteins in food and feed risk assessment
  42. Tailoring the natural rare sugars D-tagatose and L-sorbose to produce novel functional carbohydrates
  43. Relevance of gut microbiome research in food safety assessment
  44. Unexplored microbial diversity from 2,500 food metagenomes and links with the human microbiome
  45. Arabinoxylo-oligosaccharides production from unexploited agro-industrial sesame (Sesamum indicum L.) hulls waste
  46. Removal of raffinose and stachyose from soy-based beverages using soluble and immobilized MelA α-D-galactosidase from Lactiplantibacillus plantarum WCFS1
  47. Statement complementing the EFSA Scientific Opinion on application (EFSA‐GMO‐NL‐2015‐126) for authorisation of food and feed containing, consisting of and produced from genetically modified soybean MON 87705 × MON 87708 × MON 89788
  48. Valorisation of Blackcurrant Pomace by Extraction of Pectin-Rich Fractions: Structural Characterization and Evaluation as Multifunctional Cosmetic Ingredient
  49. New Pipeline for Analysing Fruit Proteolytic Products Used as Digestive Health Nutraceuticals
  50. Carob (Ceratonia siliqua) Flour as Source of Bioactive Compounds: Production, Characterization and Nutraceutical Value
  51. Design Optimization of a Novel Catalytic Approach for Transglucosylated Isomaltooligosaccharides into Dietary Polyols Structures by Leuconostoc mesenteroides Dextransucrase
  52. Sunflower Meal Valorization through Enzyme-Aided Fractionation and the Production of Emerging Prebiotics
  53. Microbiota modulatory properties of novel non-digestible xylitol-derived galacto-oligosaccharides and non-digestible lactulose derived carbohydrate mixtures
  54. Assessment of genetically modified maize DP910521 (application GMFF‐2021‐2473)
  55. Assessment of genetically modified maize MON 95275 (application GMFF‐2022‐5890)
  56. FAO technical meeting on the gut microbiome in food safety chemical risk assessment
  57. New developments in biotechnology applied to microorganisms
  58. Scientific opinion on the ANSES analysis of Annex I of the EC proposal COM (2023) 411 (EFSA‐Q‐2024‐00178)
  59. A methyl esterase from Bifidobacterium longum subsp. longum reshapes the prebiotic properties of apple pectin by triggering differential modulatory capacity i...
  60. Advancing the allergenicity assessment of new proteins using a text mining resource
  61. Assessment of genetically modified maize MON 89034 × 1507 × MON 88017 × 59122 and 8 out of 10 of its subcombinations for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF‐2022‐9170)
  62. Assessment of genetically modified maize MON 89034 × 1507 × NK603 for renewal authorisation under Regulation (EC) No 1829/2003 (application GMFF‐2022‐3670)
  63. Assessment of genetically modified maize MON 94804 (application GMFF‐2022‐10651)
  64. Assessment of genetically modified maize DP202216 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2019‐159)
  65. Prebiotic potential of new sweeteners based on the simultaneous biosynthesis of galactooligosaccharides and enzymatically modified steviol glycosides
  66. Research gaps and future needs for allergen prediction in food safety
  67. Roadmap for the integration of gastro‐intestinal (GI) tract microbiomes (human and domestic animal) in risk assessments under EFSA's remit
  68. Modeling Peptide–Protein Interactions by a Logo-Based Method: Application in Peptide–HLA Binding Predictions
  69. Assessment of genetically modified maize DP23211 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2019‐163)
  70. Assessment of genetically modified maize DP915635 for food and feed uses, under regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2020‐172)
  71. Assessment of genetically modified maize MON 810 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF‐2022‐9450)
  72. Allergenicity risk assessment of GMOs and novel foods: An overview
  73. Assessment of Novel Proteins Triggering Celiac Disease via Docking-Based Approach
  74. A review of the state of sweeteners science: the natural versus artificial non-caloric sweeteners debate. Stevia rebaudiana and Siraitia grosvenorii into the s...
  75. Physicochemical characterization and microbiota modulatory potential of brewer’s spent grain and arabinoxylan-derived fractions: A valorization study
  76. Dual 6Pβ-Galactosidase/6Pβ-Glucosidase GH1 Family for Lactose Metabolism in the Probiotic Bacterium Lactiplantibacillus plantarum WCFS1
  77. Assessment of genetically modified cotton COT102 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐DE‐2017‐141)
  78. Assessment of genetically modified maize Bt11 × MIR162 × MIR604 × MON 89034 × 5307 × GA21 and 30 subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐DE‐2018‐149)
  79. Effects of Major Families of Modulators on Performances and Gastrointestinal Microbiota of Poultry, Pigs and Ruminants: A Systematic Approach
  80. Arabinoxylan-based substrate preferences and predicted metabolic properties of Bifidobacterium longum subspecies as a basis to design differential media
  81. PMIDigest: Interactive Review of Large Collections of PubMed Entries to Distill Relevant Information
  82. Assessment of genetically modified oilseed rape MS8, RF3 and MS8 × RF3 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐024)
  83. Risk assessment of additional information on maize MIR162
  84. Dietary carbohydrates: a trade-off between appealing organoleptic and physicochemical properties and ability to control glucose release and weight management
  85. Animal dietary exposure in the risk assessment of feed derived from genetically modified plants
  86. Assessment of genetically modified maize GA21 × T25 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐DE‐2016‐137)
  87. Assessment of genetically modified maize MON 87419 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2017‐140)
  88. Isolation and structural evaluation of pectin, pectin-based polymer blends, composites, IPNs and gels
  89. Deciphering the Myrosinase-like Activity of Lactiplantibacillus plantarum WCFS1 among GH1 Family Glycoside Hydrolases
  90. Assessment of genetically modified soybean 40‐3‐2 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐023)
  91. Assessment of genetically modified soybean MON 87701 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐021)
  92. Assessment of genetically modified soybean MON 87701 × MON 89788 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐022)
  93. Insects in food and their relevance regarding allergenicity assessment
  94. Prebiotic potential of apple pomace and pectins from different apple varieties: Modulatory effects on key target commensal microbial populations
  95. Assessment of genetically modified Maize MON 87429 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2019‐161)
  96. Assessment of genetically modified maize DP4114 × MON 89034 × MON 87411 × DAS‐40278‐9 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA GMO‐NL‐2020‐171)
  97. Assessment of genetically modified maize MON 95379 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2020‐170)
  98. Assessment of genetically modified oilseed rape GT73 for placing on the market of isolated seed protein for food under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐026/2)
  99. Sustainable Food Systems: EU Regulatory Framework and Contribution of Insects to the Farm-To-Fork Strategy
  100. Assessment of genetically modified oilseed rape GT73 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐026/1)
  101. Criteria for risk assessment of plants produced by targeted mutagenesis, cisgenesis and intragenesis
  102. Updated scientific opinion on plants developed through cisgenesis and intragenesis
  103. Functional role of ST6GALNAC1‐mediated sialylation of mucins in preserving intestinal barrier integrity and ameliorating inflammation
  104. Assessment of genetically modified maize MIR162 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐025)
  105. Assessment of genetically modified maize MON 89034 × 1507 × MIR162 × NK603 × DAS‐40278‐9 for food and feed uses, under regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2018‐151)
  106. Prebiotic Potential of a New Sweetener Based on Galactooligosaccharides and Modified Mogrosides
  107. Assessment of genetically modified oilseed rape MON 94100 for food and feed uses, under regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2020‐169)
  108. Evaluation of existing guidelines for their adequacy for the food and feed risk assessment of genetically modified plants obtained through synthetic biology
  109. Risk assessment of a new bioinformatics evaluation of the insertion sites of genetically modified soybean event 40‐3‐2
  110. Structure and function of non-digestible carbohydrates in the gut microbiome
  111. Assessment of genetically modified soybean A5547‐127 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐020)
  112. Assessment of new sequencing information for genetically modified cotton DAS‐24236‐5 × DAS‐21Ø23‐5
  113. Assessment of genetically modified maize DP4114 × MON 810 × MIR604 × NK603 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2018‐150)
  114. Statement complementing the EFSA Scientific Opinion on the assessment of genetically modified oilseed rape MS11 for food and feed uses, import and processing, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐BE‐2016‐138)
  115. Production and Digestibility Studies of β-Galactosyl Xylitol Derivatives Using Heterogeneous Catalysts of LacA β-Galactosidase from Lactobacillus Plantarum WCFS1
  116. Scientific Opinion on development needs for the allergenicity and protein safety assessment of food and feed products derived from biotechnology
  117. Metabolism of Non-Digestible Dietary Carbohydrates
  118. Vegetable waste and by-products to feed a healthy gut microbiota: Current evidence, machine learning and computational tools to design novel microbiome-targeted foods
  119. Assessment of genetically modified maize NK603 × T25 × DAS‐40278‐9 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2019‐164)
  120. Production of α-rhamnosidases from Lactobacillus plantarum WCFS1 and their role in deglycosylation of dietary flavonoids naringin and rutin
  121. Ranking of immunodominant epitopes in celiac disease: Identification of reliable parameters for the safety assessment of innovative food proteins
  122. In vivo and in vitro random mutagenesis techniques in plants
  123. Bifidobacterial β-Galactosidase-Mediated Production of Galacto-Oligosaccharides: Structural and Preliminary Functional Assessments
  124. Food proteins: safety assessment and in vitro digestion
  125. Assessment of genetically modified cotton GHB811 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐ES‐2018‐154)
  126. Apple pomaces derived from mono-varietal Asturian ciders production are potential source of pectins with appealing functional properties
  127. Assessment of genetically modified cotton GHB614 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA–GMO–RX–018)
  128. Assessment of genetically modified oilseed rape 73496 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2012‐109)
  129. Statement complementing the EFSA Scientific Opinion on application (EFSA‐GMO‐NL‐2010‐85) for authorisation of food and feed containing, consisting of and produced from genetically modified soybean MON 87769 × MON 89788
  130. Assessment of genetically modified soybean GMB151 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2018‐153)
  131. Evaluation of existing guidelines for their adequacy for the molecular characterisation and environmental risk assessment of genetically modified plants obtained through synthetic biology
  132. Biosynthesis of Nondigestible Galactose-Containing Hetero-oligosaccharides by Lactobacillus plantarum WCFS1 MelA α-Galactosidase
  133. High-Yield Synthesis of Transglycosylated Mogrosides Improves the Flavor Profile of Monk Fruit Extract Sweeteners
  134. Allergenicity Assessment of Novel Food Proteins: What Should Be Improved?
  135. Assessment of genetically modified maize 1507 × MIR162 × MON810 × NK603 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2015‐127)
  136. Assessment of genetically modified maize Bt11 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐016)
  137. Assessment of genetically modified maize MON 87427 × MON 87460 × MON 89034 × 1507 × MON 87411 × 59122 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2017‐139)
  138. Assessment of genetically modified maize MON 88017 × MON 810 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐017)
  139. Behaviour of citrus pectin and modified citrus pectin in an azoxymethane/dextran sodium sulfate (AOM/DSS)-induced rat colorectal carcinogenesis model
  140. Statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants
  141. Hydrolysis and transglycosylation activities of glycosidases from small intestine brush-border membrane vesicles
  142. Transglycosylation of Steviol Glycosides and Rebaudioside A: Synthesis Optimization, Structural Analysis and Sensory Profiles
  143. Adequacy and sufficiency evaluation of existing EFSA guidelines for the molecular characterisation, environmental risk assessment and post‐market environmental monitoring of genetically modified insects containing engineered gene drives
  144. Applicability of the EFSA Opinion on site‐directed nucleases type 3 for the safety assessment of plants developed using site‐directed nucleases type 1 and 2 and oligonucleotide‐directed mutagenesis
  145. Scientific Opinion on application EFSA‐GMO‐NL‐2016‐132 for authorisation of genetically modified of insect‐resistant and herbicide‐tolerant soybean DAS–81419–2 × DAS–44406–6 for food and feed uses, import and processing submitted in accordance with Reg...
  146. Bringing the digestibility of prebiotics into focus: update of carbohydrate digestion models
  147. Prebiotic Properties of Non-Fructosylated α-Galactooligosaccharides from PEA (Pisum sativum L.) Using Infant Fecal Slurries
  148. Assessment of genetically modified oilseed rape GT73 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐002)
  149. Statement complementing the EFSA Scientific Opinion on application (EFSA‐GMO‐NL‐2009‐75) for placing on the market of genetically modified oilseed rape Ms8 × Rf3 × GT73 and subcombinations, which have not been authorised previously (i.e. Ms8 × GT73 and...
  150. Hydrolysis of Lactose and Transglycosylation of Selected Sugar Alcohols by LacA β-Galactosidase from Lactobacillus plantarum WCFS1
  151. Andean tubers grown in Ecuador: New sources of functional ingredients
  152. Assessment of genetically modified maize MZIR098 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐DE‐2017‐142)
  153. Physical properties of synbiotic yogurts as affected by the acidification rate
  154. Unravelling the carbohydrate specificity of MelA from Lactobacillus plantarum WCFS1: An α-galactosidase displaying regioselective transgalactosylation
  155. Assessment of genetically modified oilseed rape MS11 for food and feed uses, import and processing, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐BE‐2016‐138)
  156. Assessment of genetically modified soybean MON 87705 × MON 87708 × MON 89788, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2015‐126)
  157. Hydrolysis and transgalactosylation catalysed by β-galactosidase from brush border membrane vesicles isolated from pig small intestine: A study using lactulose and its mixtures with lactose or galactose as substrates
  158. Metabolism of biosynthetic oligosaccharides by human-derived Bifidobacterium breve UCC2003 and Bifidobacterium longum NCIMB 8809
  159. Assessment of genetically modified maize MON 88017 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐014)
  160. Probiotic viability in yoghurts containing oligosaccharides derived from lactulose (OsLu) during fermentation and cold storage
  161. Advances in structure elucidation of low molecular weight carbohydrates by liquid chromatography-multiple-stage mass spectrometry analysis
  162. Assessment of genetically modified soybean SYHT0H2 for food and feed uses, import and processing, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐DE‐2012‐111)
  163. Determination by HPLC-DAD-ESI/MSn of phenolic compounds in Andean tubers grown in Ecuador
  164. Morphological, technological and nutritional properties of flours and starches from mashua (Tropaeolum tuberosum) and melloco (Ullucus tuberosus) cultivated in Ecuador
  165. Assessment of genetically modified maize MIR604 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐013)
  166. Assessment of genetically modified maize MON 87427 × MON 89034 × MIR162 × MON 87411 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2017‐144)
  167. Assessment of genetically modified maize MON 89034 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐015)
  168. Assessment of genetically modified soybean MON 87751 × MON 87701 × MON 87708 × MON 89788 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2016‐128)
  169. Statement complementing the EFSA Scientific Opinion on application (EFSA‐GMO‐UK‐2006‐34) for authorisation of food and feed containing, consisting of and produced from genetically modified maize 3272
  170. Unravelling the diversity of glycoside hydrolase family 13 α-amylases from Lactobacillus plantarum WCFS1
  171. Editorial: Dietary Carbohydrate Digestibility and Metabolic Effects in Human Health
  172. High-yield purification of commercial lactulose syrup
  173. Assessment of genetically modified maize MON 87427 × MON 87460 × MON 89034 × MIR162 × NK603 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2016‐134)
  174. Safety Assessment of Immune-Mediated Adverse Reactions to Novel Food Proteins
  175. Separation of di- and trisaccharide mixtures by comprehensive two-dimensional liquid chromatography. Application to prebiotic oligosaccharides
  176. Assessment of genetically modified maize MON 87427 × MON 89034 × MIR162 × NK603 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2016‐131)
  177. Assessment of genetically modified soybean MON 87708 × MON 89788 × A5547‐127, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2016‐135)
  178. Selective biotechnological fractionation of goat milk carbohydrates
  179. Fermentative properties of starter culture during manufacture of kefir with new prebiotics derived from lactulose
  180. In vitro Digestibility of Dietary Carbohydrates: Toward a Standardized Methodology Beyond Amylolytic and Microbial Enzymes
  181. In Vitro Digestibility of Galactooligosaccharides: Effect of the Structural Features on Their Intestinal Degradation
  182. Assessment of genetically modified maize Bt11 × MIR162 × MIR604 × 1507 × 5307 × GA21 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐DE‐2011‐103)
  183. Behaviour of citrus pectin during its gastrointestinal digestion and fermentation in a dynamic simulator (simgi®)
  184. Effect of selected prebiotics on the growth of lactic acid bacteria and physicochemical properties of yoghurts
  185. Assessment of genetically modified oilseed rape T45 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐012)
  186. Trans-β-galactosidase activity of pig enzymes embedded in the small intestinal brush border membrane vesicles
  187. Structural and Rheological Properties of Pectins Extracted from Industrial Sugar Beet By-Products
  188. Assessment of genetically modified maize MON 89034 × 1507 × MON 88017 × 59122 × DAS‐40278‐9 and subcombinations independently of their origin for food and feed uses, import and processing under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐NL‐2013...
  189. Assessment of genetically modified maize MON 89034 × 1507 × NK603 × DAS‐40278‐9 and subcombinations independently of their origin for food and feed uses, import and processing, under Regulation (EC) No 1829‐2003 (application EFSA‐GMO‐NL‐2013‐112)
  190. Assessment of genetically modified soybean A2704‐12 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐009)
  191. Dietary Carbohydrate Digestibility and Metabolic Effects in Human Health
  192. Glycation affects differently the main soybean Bowman–Birk isoinhibitors, IBB1 and IBBD2, altering their antiproliferative properties against HT29 colon cancer cells
  193. In vitro fermentation properties of pectins and enzymatic-modified pectins obtained from different renewable bioresources
  194. Sweetness and sensory properties of commercial and novel oligosaccharides of prebiotic potential
  195. Assessment of genetically modified LLCotton25 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐010)
  196. Assessment of genetically modified maize MZHG0JG for food and feed uses, import and processing under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐DE‐2016‐133)
  197. Assessment of genetically modified soybean MON 89788 for renewal of authorisation under Regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐011)
  198. Chemical and physicochemical characterization of orange by-products derived from industry
  199. A Galacto-Oligosaccharides Preparation Derived From Lactulose Protects Against Colorectal Cancer Development in an Animal Model
  200. Stability of Oligosaccharides Derived from Lactose and Lactulose regarding Rheological and Thermal Properties
  201. Anti-inflammatory bowel effect of industrial orange by-products in DSS-treated mice
  202. Application of a commercial digestive supplement formulated with enzymes and probiotics in lactase non-persistence management
  203. Enzymatic Synthesis and Structural Characterization of Theanderose through Transfructosylation Reaction Catalyzed by Levansucrase from Bacillus subtilis CECT 39
  204. Modification of citrus and apple pectin by power ultrasound: Effects of acid and enzymatic treatment
  205. Assessment of in Vitro Digestibility of Dietary Carbohydrates Using Rat Small Intestinal Extract
  206. Guidance on allergenicity assessment of genetically modified plants
  207. Effect of glycation and limited hydrolysis on interfacial and foaming properties of bovine β-lactoglobulin
  208. Changes in Caprine Milk Oligosaccharides at Different Lactation Stages Analyzed by High Performance Liquid Chromatography Coupled to Mass Spectrometry
  209. Impact of High‐intensity Ultrasound on Protein Structure and Functionality during Food Processing
  210. Chromatography
  211. Assessment of endogenous allergenicity of genetically modified plants exemplified by soybean – Where do we stand?
  212. Current state and latest advances in the concept, production and functionality of prebiotic oligosaccharides
  213. Tofu Whey Permeate Is an Efficient Source To Enzymatically Produce Prebiotic Fructooligosaccharides and Novel Fructosylated α-Galactosides
  214. Genome Structure of the Symbiont Bifidobacterium pseudocatenulatum CECT 7765 and Gene Expression Profiling in Response to Lactulose-Derived Oligosaccharides
  215. Synthesis and structural characterization of raffinosyl-oligofructosides upon transfructosylation by Lactobacillus gasseri DSM 20604 inulosucrase
  216. Characterization of goat colostrum oligosaccharides by nano-liquid chromatography on chip quadrupole time-of-flight mass spectrometry and hydrophilic interaction liquid chromatography-quadrupole mass spectrometry
  217. In vitro faecal fermentation of novel oligosaccharides enzymatically synthesized using microbial transglycosidases acting on sucrose
  218. Characterization of post-translationally modified peptides by hydrophilic interaction and reverse phase liquid chromatography coupled to quadrupole-time-of-flight mass spectrometry
  219. Synthesis of potentially-bioactive lactosyl-oligofructosides by a novel bi-enzymatic system using bacterial fructansucrases
  220. Valorization of Cheese and Tofu Whey through Enzymatic Synthesis of Lactosucrose
  221. Kojibiose ameliorates arachidic acid-induced metabolic alterations in hyperglycaemic rats
  222. Stability of oligosaccharides derived from lactulose during the processing of milk and apple juice
  223. Use of room temperature ionic liquids for the selective fractionation of bioactive ketoses from aldoses
  224. Synthesis and Characterization of Isomaltulose-Derived Oligosaccharides Produced by Transglucosylation Reaction of Leuconostoc mesenteroides Dextransucrase
  225. Influence of Chemical Structure on the Solubility of Low Molecular Weight Carbohydrates in Room Temperature Ionic Liquids
  226. Selective fermentation of potential prebiotic lactose-derived oligosaccharides by probiotic bacteria
  227. Impact of high-intensity ultrasound on the formation of lactulose and Maillard reaction glycoconjugates
  228. Synthesis of novel bioactive lactose‐derived oligosaccharides by microbial glycoside hydrolases
  229. Food Oligosaccharides
  230. Index
  231. Fractionation of Food Bioactive Oligosaccharides
  232. Acute Oral Safety Study of Sodium Caseinate Glycosylated via Maillard Reaction with Galactose in Rats
  233. Analysis, structural characterization, and bioactivity of oligosaccharides derived from lactose
  234. A sustainable biotechnological process for the efficient synthesis of kojibiose
  235. Structural differences of prebiotic oligosaccharides influence their capability to enhance iron absorption in deficient rats
  236. Neoglycoconjugates of caseinomacropeptide and galactooligosaccharides modify adhesion of intestinal pathogens and inflammatory response(s) of intestinal (Caco-2) cells
  237. Galacto-oligosaccharides Derived from Lactulose Exert a Selective Stimulation on the Growth of Bifidobacterium animalis in the Large Intestine of Growing Rats
  238. In vitro bifidogenic effect of Maillard-type milk protein–galactose conjugates on the human intestinal microbiota
  239. Enzymatic Synthesis and Characterization of Fructooligosaccharides and Novel Maltosylfructosides by Inulosucrase from Lactobacillus gasseri DSM 20604
  240. Assessment of interfacial and foaming properties of bovine sodium caseinate glycated with galactose
  241. Synthesis of prebiotic carbohydrates derived from cheese whey permeate by a combined process of isomerisation and transgalactosylation
  242. Efficient Synthesis and Characterization of Lactulosucrose by Leuconostoc mesenteroides B-512F Dextransucrase
  243. Proteomic analysis of processing by-products from canned and fresh tuna: Identification of potentially functional food proteins
  244. Hydrolyzed Caseinomacropeptide Conjugated Galactooligosaccharides Support the Growth and Enhance the Bile Tolerance in Lactobacillus Strains
  245. Interfacial and foaming properties of bovine β-lactoglobulin: Galactose Maillard conjugates
  246. Effect of prebiotic carbohydrates on the growth and tolerance of Lactobacillus
  247. Monomer and Linkage Type of Galacto-Oligosaccharides Affect Their Resistance to Ileal Digestion and Prebiotic Properties in Rats1–3
  248. Growth and transcriptional response of Salmonella Typhimurium LT2 to glucose–lysine-based Maillard reaction products generated under low water activity conditions
  249. Synthesis and Characterization of a Potential Prebiotic Trisaccharide from Cheese Whey Permeate and Sucrose by Leuconostoc mesenteroides Dextransucrase
  250. Effect of milk protein glycation and gastrointestinal digestion on the growth of bifidobacteria and lactic acid bacteria
  251. Hydrophilic interaction liquid chromatography coupled to mass spectrometry for the characterization of prebiotic galactooligosaccharides
  252. CHAPTER 13. Analysis of Dietary Sugars in Beverages by Gas Chromatography
  253. Effect of glycation of bovine β-lactoglobulin with galactooligosaccharides on the growth of human faecal bacteria
  254. Maillard-type glycoconjugates from dairy proteins inhibit adhesion of Escherichia coli to mucin
  255. In Vitro Fermentation by Human Gut Bacteria of Proteolytically Digested Caseinomacropeptide Nonenzymatically Glycosylated with Prebiotic Carbohydrates
  256. Detection of Two Minor Phosphorylation Sites for Bovine κ-Casein Macropeptide by Reversed-Phase Liquid Chromatography–Tandem Mass Spectrometry
  257. Characterization of galactooligosaccharides derived from lactulose
  258. Effect of glycation on sodium caseinate-stabilized emulsions obtained by ultrasound
  259. Effect of glycation on the gastrointestinal digestibility and immunoreactivity of bovine β-lactoglobulin
  260. Development of a new method using HILIC-tandem mass spectrometry for the characterization of O-sialoglycopeptides from proteolytically digested caseinomacropeptide
  261. Selective linkage detection ofO-sialoglycan isomers by negative electrospray ionization ion trap tandem mass spectrometry
  262. The cytotoxic effect of Bowman-Birk isoinhibitors, IBB1 and IBBD2, from soybean (Glycine max) on HT29 human colorectal cancer cells is related to their intrinsic ability to inhibit serine proteases
  263. Role of Pyridoxamine in the Formation of the Amadori/Heyns Compounds and Aggregates during the Glycation of β-Lactoglobulin with Galactose and Tagatose
  264. Characterization and improvement of rheological properties of sodium caseinate glycated with galactose, lactose and dextran
  265. Application of liquid chromatography–tandem mass spectrometry for the characterization of galactosylated and tagatosylated β-lactoglobulin peptides derived from in vitro gastrointestinal digestion
  266. Recent Advances in the Recovery and Improvement of Functional Proteins from Fish Processing By-Products: Use of Protein Glycation as an Alternative Method
  267. Comparison of fractionation techniques to obtain prebiotic galactooligosaccharides
  268. Glycosylated dairy components: Their roles in nature and ways to make use of their biofunctionality in dairy products
  269. Protein Quality, Antigenicity, and Antioxidant Activity of Soy-Based Foodstuffs
  270. Mass Spectrometric Characterization of Glycated β-Lactoglobulin Peptides Derived from Galacto-oligosaccharides Surviving the In Vitro Gastrointestinal Digestion
  271. Structural Characterization of Bovine β-Lactoglobulin−Galactose/Tagatose Maillard Complexes by Electrophoretic, Chromatographic, and Spectroscopic Methods
  272. 2S Albumin Storage Proteins: What Makes them Food Allergens?
  273. Characterization and in Vitro Digestibility of Bovine β-Lactoglobulin Glycated with Galactooligosaccharides
  274. Isolation of bovine β-lactoglobulin from complexes with chitosan
  275. Optimized techniques for the extraction of grape allergens appropriate for in vivo and in vitro testing and diagnosis
  276. Gastrointestinal digestion of food allergens: Effect on their allergenicity
  277. In vitro glycation and antigenicity of soy proteins
  278. The effects of food processing on allergens
  279. The effects of food processing on allergens
  280. Uptake of 2S Albumin Allergens, Ber e 1 and Ses i 1, across Human Intestinal Epithelial Caco-2 Cell Monolayers
  281. Changes in antioxidant activity of dehydrated onion and garlic during storage
  282. Effect of in vitro gastric and duodenal digestion on the allergenicity of grape lipid transfer protein
  283. Use of Chitosan for Selective Removal of β-Lactoglobulin from Whey
  284. Phospholipid Interactions Protect the Milk Allergen α-Lactalbumin from Proteolysis during in Vitro Digestion
  285. Assessment of Initial Stages of Maillard Reaction in Dehydrated Onion and Garlic Samples
  286. Thermostability and in vitro digestibility of a purified major allergen 2S albumin (Ses i 1) from white sesame seeds (Sesamum indicum L.)
  287. A Reliable Gas Capillary Chromatographic Determination of Lactulose in Dairy Samples
  288. Glycation of caseinmacropeptide
  289. Selective Recovery of Glycosylated Caseinmacropeptide with Chitosan
  290. Stability of the major allergen Brazil nut 2S albumin (Ber e 1) to physiologically relevant in vitro gastrointestinal digestion
  291. Conference report
  292. Processing approaches to reducing allergenicity in proteins
  293. Mass spectrometry and structural characterization of 2S albumin isoforms from Brazil nuts (Bertholletia excelsa)
  294. Processing approaches to reducing allergenicity in proteins
  295. Effect of High Pressure on Isomerization and Degradation of Lactose in Alkaline Media
  296. High-Pressure Effects on Maillard Reaction between Glucose and Lysine
  297. Heterogeneity of Caprine Beta-Casein Elucidated by RP-HPLC/MS: Genetic Variants and Phosphorylations
  298. Characterization and Functional Properties of Lactosyl Caseinomacropeptide Conjugates
  299. Interfacial Behavior of Goat Kappa Casein: Ellipsometry and Atomic Force Microscopy Study
  300. Heterogeneity of caprine κ-casein macropeptide
  301. Analysis of monosaccharides in bovine, caprine and ovine κ-casein macropeptide by gas chromatography
  302. Chromatographic characterization of ovine κ-casein macropeptide
  303. Determination of maltodextrins in enteral formulations by three different chromatographic methods
  304. Controlling processing in complex food systems: a potential route to food-allergy prevention